Introduction
Polycystic ovary syndrome is one of the most common endocrine disorders in women of reproductive age, affecting 5% to 10% of women worldwide. This familial disorder inherited as a complex genetic trait 1 . It is characterized by a combination of hyperandrogenism (either clinical or biochemical), chronic anovulation, and polycystic ovaries. It is frequently associated with insulin resistance and obesity 2 . PCOS receives considerable attention because of its high prevalence and possible reproductive, metabolic, and cardiovascular consequences. Studies in first-degree relatives of patients who have PCOS have shown that 24% of mothers and 32% of sisters are affected, suggesting a major genetic association 3 .The disease begins soon after puberty mostly 15-25 years of age and commonly manifests during reproductive period. Health consequences of PCOS relate to insulin resistance and hyperandrogenism. They include diabetes, obesity, metabolic syndrome (MS), endometrial hyperplasia, anovulatory infertility, and depression. Risk for diabetes has been shown to be higher in women and adolescents who have PCOS. Studies have shown that in women who have PCOS, 7.5% to 10% had type2 diabetes and approximately 30% to 35% had impaired glucose tolerance 4, 5 . Impaired glucose tolerance is known to be a significant risk factor for developing diabetes, as was shown in the Diabetes Prevention Trial. The rate of conversion from IGT to type 2DM is increased 5-15 fold in PCOS 6 . Multiple factors contribute to diabetes risk in women with PCOS. The risk factors are obesity, Insulin resistance, decreased peripheral insulin sensitivity, Centripetal fat distribution, Hyperinsulinemia, Beta-cell dysfunction, Chronic anovulation, Family history of type 2 diabetes, dyslipidemia 7 .
Aim and Objectives of the Study
 To study the prevalence of impaired glucose tolerance and diabetes in young women (15 to 25 yrs) with PCOS in relation to age, socioeconomic status, rural and urban areas, Body mass index (BMI), waist/hip circumference ratio, family history of PCOS and diabetes mellitus, so as to facilitate prevention of long term consequences.
II. Review of Literature
Historical Perspective Multicystic or -sclerocystic‖ ovaries were recognized as early as the mid-18th century, associated primarily with pelvic pain or menorrhagia 8 . 1921-The association between disorders of carbohydrate metabolism and hyperandrogenism was first described by Achard and Thiers. -diabetedes femmes a barbe‖ (diabetes of bearded lady) 9 . 1935-Stein and Leventhal recognized an association between the presence of bilateral polycystic ovaries and signs of amenorrhea, oligomenorrhea, hirsutism and obesity then known as Stein-Leventhal syndrome 10 . 1964-Stein reported the reversal to normal menstrual cycles and conceptions after bilateral ovarian wedge resection in a significant number of PCOS patients. 1980-Burghen and coworkers first reported a close association of hyperandrogenism and hyperinsulinemia in PCOS women 11 .. 12 in 2014 analysed the association of family history of T2DM and PCOS. Results: A positive FHx of T2DM and PCOS were prevalent in 36.8 and 21.4% of PCOS women respectively. 2. Vrbikova J et al 13 in 2014 evaluated the utility of impaired fasting plasma glucose as defined by ADA to identify women with PCOS affected by impaired glucose metabolism. Conclusion-fasting plasma glucose is not sufficiently sensitive for the detection of impaired glucose tolerance and diabetes mellitus type 2 in women with PCOS. 14 carried out case-control observational study on 263 women confirmed to have PCOS based on Rotterdam criteria. Although, there were no significant differences in IR, MS and glucose intolerance between the four PCOS phenotypes, women with PCOS are at higher risk of impaired glucose tolerance and undiagnosed diabetes. 4. Flannery CA etal 15 in 2013 studied Polycystic ovary syndrome in adolescence. Conclusion-abnormal glucose metabolism is highly prevalent in adolescents with PCOS. In particular, IGT occurs across the spectrum of BMI. A screening OGTT should be considered for adolescents diagnosed with PCOS, independently of their BMI.
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DIAGNOSIS
Diagnosis of PCOS is after exclusion of other aetiologies that mimic PCOS Criteria for the Definition of PCOS-NIH Statement (1990) 16 To include all of the following: 1. Hyperandrogenism and/or hyperandrogenemia 2. Oligo-ovulation 3. Exclusion of related disorders -Including but not limited to 21-hydroxylase-deficient nonclassic adrenal hyperplasia, thyroid dysfunction, hyperprolactinemia, neoplastic androgen secretion,drug-induced androgen excess, the syndromes of severe insulin resistance, Cushing's syndrome, and glucocorticoid resistance. 17 To include two of the following, in addition to exclusion of related disorders: 1. Oligo-ovulation or anovulation (e.g., amenorrhea, irregular uterine bleeding) 2. Clinical and/or biochemical signs of hyperandrogenism (e.g., hirsutism, elevated serum total or free testosterone) 3. Polycystic ovaries (by ultrasonography) 18 To include all of the following: 1. Hyperandrogenism: hirsutism and/or hyperandrogenemia 2. Ovarian dysfunction: oligo-anovulation and/or polycystic ovaries 3. Exclusion of other androgen excess or related disorders.
ESHRE/ASRM Statement (Rotterdam, 2003)
AES Suggested Criteria for the Diagnosis of PCOS (2006)
Differential Diagnosis of Polycystic Ovary Syndrome
-Idiopathic hirsutism -Hyperprolactinemia -Hypothyroidism -Nonclassic adrenal hyperplasia -Ovarian tumors or Virilising adrenal tumours -Cushing's syndrome -Glucocorticoid resistance -Current or previous use of oral contraceptives, glucocorticoids, ovulation induction agents, anti-diabetic drugs, sodium valproate, aspirin, statins, and other hormonal drugs.
Insulin Resistance
Euglycemic glucose clamp studies have demonstrated significant and substantial decreases in insulin-mediated glucose uptake in PCOS. This decrease (approximately 35% to 40%) is of a similar magnitude to that seen in type 2 diabetes and is independent of obesity, glucose intolerance, increases in waist-hip-girth ratio, and differences in muscle mass 20 .
Family History of Type 2 Diabetes
First-degree relatives of patients with type 2 diabetes are more likely to experience the stigmata of insulin resistance, including impaired glucose tolerance. Diabetes risk is increased according to the number of relatives affected with type 2 diabetes and the closeness of the relation 21 .
The Effects of Age on Insulin Resistance
Glucose tolerance tends to worsen with age,due to progressive beta-cell dysfunction. Impaired glucose tolerance is a risk factor for the development of type 2 diabetes, with an average conversion rate of 1% to 5% per year. Cumulative conversion rates are as high as 80% over 5 years 22 .
III. Material And Methods
The present study includes 100 young women aged between 15 to 25 years diagnosed to have polycystic ovarian syndrome presenting to the Department of Obstetrics and Gynaecology, Gandhi Hospital, Secunderabad. PCOS was defined when at least two of the above features were present after exclusion of other conditions that mimic PCOS.
Exclusion criteria:
 Hypothyroidism  Hyperprolactinemia  Cushing's syndrome  Congenital adrenal hyperplasia  Adrenal tumors  Current or previous (within the last months) use of oral contraceptives, glucocorticoids, antiandrogens, ovulation induction agents, anti diabetic drugs, sodium valproate, aspirin, statins and other hormonal drugs.
Informed consent is obtained from all subjects after explanation of the nature and purpose of the study. A detailed history regarding their age, place, socio-economic status, health status, menstrual history, hirsutism, acne, weight gain, height, weight, food habits, life style,menstrual history, obstetric history, use of meditations including O.C. pills, family history of PCOS, diabetes mellitus is taken.
IV. Methods
Height is measured bare foot to the nearest 0.5 Cm. Weight is measured to the nearest 0.5 Kg. Body mass Index (BMI), waist/hip ratio is calculated. The presence of hirsutism was noted in every woman quantitating the presence of terminal hairs over nine body areas (i.e. upper lip, chin, chest, upper and lower abdomen, upper and lower back, upper arm and things) according to Ferriman-Gallway score. The presence or absence of acne, androgenic alopecia, acanthosis nigricans was recorded. After a 3-day carbohydrate diet (150 g/day) and an over -night fasting for 8 to 10 hours, a standard OGTT (1.75 g/kg or a maximum of 75 g of glucose) was performed for all subjects. (15 Prevalence of impaired glucose tolerance and diabetes in PCOS in relation to age, socioeconomic status, Domicile-rural and urban areas, BMI, waist/hip circumference ratio, family history of PCOS and diabetes mellitus was measured.
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Statistical Analysis
Data analysis-observations were tabulated on a sheet by using Microsoft excel. Statistical analysis of the patients was carried out with chi square test using SPSS software. A "p" value <0.05 was considered statistically significant. Table 1 -Distribution of patients according to the age GRAPH 1-Distribution of patients according to the age GRAPH 4 -Distribution of patients based on BMI Prevalence of glucose intolerance is more in urban population compared to rural population as BMI is high in urban population probably due to life style. p value is 0.05, association is significant. Glucose intolerance is more in higher socio economic status compared to lower socio economic status probably due to high BMI and life style changes. Chi-square value is 2.64, p value >0.5, Association is not statistically significant. 
V. Results
GRAPH 15-Prevalence of Glucose intolerance by Family H/O PCOS
Glucose intolerance more common is women with family H/O PCOS probably due to genetic causes. In the present study p value is >0.05, Association is not statistically significant. 
VI. Discussion
PCOS is most frequently encountered endocrinopathy in women of reproductive age. Having the disorder may significantly impact the quality of life of women during the reproductive years, and it contributes to morbidity and mortality by the time of menopause, like increased risk for IGT and type 2 diabetes mellitus compared to concurrently studied age, weight, comparable reproductively normal women.
In general women with PCOS, even those who are glucose intolerant, often have a normal Fasting Blood Glucose. Currently, guidelines from the Androgen Excess Society recommend that a 2-hour OGTT be performed on all women with PCOS. Strategies designed to prevent or delay its onset have recently received great attention. One approach is to identify populations highly predisposed to NIDDM especially IGT were targeted to allow intervention at a point prior to its development., since if left untreated, NIDDM will develop at an average rate of 6% per year, with rates as high as almost 9%.
In the present study 100 young women with PCOS, age between 15 to 25 years are screened for abnormal glucose tolerance and diabetes mellitus. 
GRAPH 24 Comparison of prevalence of IGT, DM with other studies
The results of present study are consistent with studies done by Maida Yousif, Weerakiet, Seneviratne. Prevalence of IGT in studies of Cristano, David Ehrmann, Legro are higher than in present study as mean age, and BMI are higher in those studies than in present study. Age and BMI are risk factors for impaired glucose metabolism. In present study, the subjects were young, with an average age of 23.05 years. As age was identified as a confounder for BMI and BMI is related to insulin resistance, the young age of our study population may explain the low incidence of IGT in present study. Prevalence of IGT in studies of Palmert, Pantasri are higher than in present study may be due to smaller sample size. Like other studies we noted that the FPG test failed to predict the majority of the subjects with IGT. If we considered only the fasting plasma glucose value as a diagnostic criterion for Abnormal glucose metabolism (AGM), 17 patients would be missed.
In present study, the prevalence of impaired glucose went from 6% using the FPG test to 22% with the 2-hour OGTT, reinforcing the recommendation that women with PCOS be screened for glucose intolerance with the 2-hour OGTT. (15 
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GRAPH 26 COMPARISION OF PREVALENCE OF AGM (IGT+DM), IGT, DM % BY AGE IN PCOS WOMEN
Although IGT and diabetes were detected in young women, the prevalence of both were increased with age. The results are consistent with studies by Cristano and Maida Yousif. Prevalence OF IGT, DM is more in women with high BMI in present study, similar to other studies. Prevalence of IGT in study of Cristano are higher than in present study as mean BMI are higher in that study than in present study. Prevalence of IGT in present study is more than in study by Elisabeth, Kavitha mandrelle where mean BMI is low in obese women, excess insulin and androgens may contribute to the development of PCOS and metabolic abnormalities. The android pattern of fat distribution may be the result as well as the cause of hyperandrogenism, setting up a vicious circle of hyperinsulinism, hyperandrogenism, central adiposity, and metabolic abnormalities. Present study found an about 1.7-fold increased risk of of glucose intolerance in PCOS women with a positive FHx of T2DM. Thus, our findings are consistent with a genetic basis for metabolic disturbances in PCOS. The higher prevalence in this study compared to ELISABETH study could be a result of our smaller sample size.
Further, Ehrmann et al found a 2.6-fold higher prevalence of first-degree relatives with T2DM in 12 PCOS women with T2DM compared with 67 PCOS women with normal glucose tolerance (83 vs 31%). That study again differed from present study with respect to BMI (mean BMI 33.4, 36.9 and 41.0 kg/m2 for women with normal glucose tolerance, IGT and T2DM respectively). A larger study by Ehrmann including 408 women with PCOS found a positive FHx of T2DM in 44% of the 16 diabetic PCOS women, 39% of the 94 women with impaired glucose tolerance and 21% of the 298 women with normal glucose tolerance. Positive Family H/O of T2DM is independently associated with metabolic disturbances such as central fat accumulation, obesity, prediabetes. Conversely, the prevalence of IGT and T2DM was significantly higher in PCOS women with a positive FHx of T2DM, which is in line with the findings of our study. Again, that study was conducted in the US and included women with a mean BMI of 36.2 kg/m2
A positive FHx of PCOS, however, was independently associated with clinical and biochemical hyperandrogenism and prediabetes. PCOS women with a positive FHx of both T2DM and PCOS had the highest prevalence of metabolic disturbances and hyperandrogenism . 2-hr OGTT should be carried out in all women with PCOS, which has also been suggested by the new Endocrine Society Clinical Practice Guidelines.
Further, the assumption of a common genetic background of PCOS and T2DM is strengthened by our results showing that both obese as well as non-obese PCOS women with a positive T2DM FHx are more likely to have a positive PCOS FHx. First and clinically most important, the simple assessment whether a relative is affected by T2DM or not might allow risk stratification of PCOS women. It might help identify PCOS women at high metabolic risk in whom further evaluation including a regular follow-up as well as intensified treatment are indicated.
In the present study Prevalence of glucose intolerance 1. is more in urban population compared to rural population as BMI is high in urban population probably due to life style changes. p value is 0.05, association is significant. 2. is more in higher socio economic status compared to lower socio economic status probably due to high BMI and life style changes. In the present study oligomenorrhoea, hirsutism, Acne, infertility, acanthosis nigricans are more prevalent in PCOS women with impaired glucose tolerance than in women with normal glucose tolerance. Hirsutism, acanthosis nigricans are caused by hyperinsulinemia.
VII. Conclusion
PCOS women have significantly increased prevalence rates of IGT and diabetes with 1.With obesity -especially central and increasing with the BMI, but also can occur even in young, non-obese PCO women. The main focus of the majority of PCOS women who seek treatment at hospital is their reproductive problem ranging from the menstrual to the infertility problem, but are not aware of the risk of developing metabolic and cardiovascular complications in later life. Fasting glucose levels are poor predictors of diabetes in PCOS women. &. IGT occurs across the spectrum of BMI . But glucose levels at 2 hours on the OGTT (the WHO criteria) identified more patients than fasting glucose level. Thus, to adequately define the at-risk population, oral glucose tolerance testing is advisable in all PCOS women at the time of diagnosis and yearly thereafter .
Hence a screening OGTT should be considered for adolescents diagnosed with PCOS, independently of their BMI. During this process of screening we can implement primary prevention that includes health education, healthy life style modification, weight reduction. Taken together, it appears that women with PCOS are an ideal population for implementing strategies for the prevention of NIDDM.
